Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paramount Bed Holdings Co's revenue per share for the
three
months ended in Sep. 2025 was $3.00.
Paramount Bed Holdings Co's revenue per share for the trailing twelve months (TTM) ended in Sep. 2025 was $5.75.
Warning Sign:
Paramount Bed Holdings Co Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Paramount Bed Holdings Co was -29.00% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 7.00% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 6.70% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 5.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Paramount Bed Holdings Co's Revenue per Share or its related term are showing as below:
PBHDF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.9 Med: 6.1 Max: 13.4
Current: 7
During the past 13 years, Paramount Bed Holdings Co's highest 3-Year average Revenue Per Share Growth Rate was 13.40% per year. The lowest was -7.90% per year. And the median was 6.10% per year.
PBHDF's 3-Year Revenue Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.7
vs PBHDF: 7.00
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Paramount Bed Holdings Co Revenue per Share Related Terms
Paramount Bed Holdings Co Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PBHDF vs ISRG, BDX, MDLN: Revenue per Share Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's PS Ratio falls into.
Paramount Bed Holdings Co Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Paramount Bed Holdings Co's Revenue Per Share for the fiscal year that ended in Mar. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (PBHDF) has a Revenue per Share of $5.75 as of Sep. 2025. Revenue per share equals the per-share value of a company's sales. View historical data on Paramount Bed Holdings Co and its competitors.
Is Paramount Bed Holdings Co's Revenue per Share too high?
Paramount Bed Holdings Co's current Revenue per Share is $5.75. The Medical Devices & Instruments industry median Revenue per Share is 3.70. Paramount Bed Holdings Co's value of $5.75 is 55.4% above this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Revenue per Share compare to ISRG and BDX?
Paramount Bed Holdings Co's Revenue per Share of $5.75 can be compared against companies in the Medical Devices & Instruments industry. The industry median Revenue per Share is 3.70. Paramount Bed Holdings Co's value of $5.75 is 55.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.70, based on 754 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current Revenue per Share of $5.75 is 55.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current Revenue per Share is $5.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current Revenue per Share of $5.75. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current Revenue per Share is $5.75 and 55.4% above the Medical Devices & Instruments industry median of 3.70. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current Revenue per Share is $5.75 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
Revenue per Share: $5.75
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
Industry Position: 55.4% above the Medical Devices & Instruments median
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
